Validation of a Method for Assay of Trifluoroacetates in the Pharmaceutical Substance Glatiramer Acetate by 19F NMR Spectroscopy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

A procedure for validation of an assay method for fluorine in residual trifluoroacetates in the pharmaceutical substance glatiramer acetate by 19F NMR spectroscopy is described. The method provides for assay of the content of trifluoroacetates without destruction of the substance under analysis. The validation process established the detection limit and assessed the linearity, accuracy, convergence, intralaboratory precision, and specificity of the method under validation. Measurement of “found:added” coefficients were used to calculate standard deviations, coefficients of variation, significance intervals, and systematic errors, using Fisher’s F test and Student’s t test to assess the assay results. The statistical characteristics were found to satisfy the criteria for acceptability of the validation parameters given in Russian and foreign normative documentation.

About the authors

S. V. Moiseev

Scientific Center for Expertise in Medicines, Ministry of Health of the Russian Federation

Author for correspondence.
Email: MoiseevSV@expmed.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

N. E. Kuz’mina

Scientific Center for Expertise in Medicines, Ministry of Health of the Russian Federation

Email: MoiseevSV@expmed.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

V. I. Krylov

Scientific Center for Expertise in Medicines, Ministry of Health of the Russian Federation

Email: MoiseevSV@expmed.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

V. A. Yashkir

Scientific Center for Expertise in Medicines, Ministry of Health of the Russian Federation

Email: MoiseevSV@expmed.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

V. A. Merkulov

Scientific Center for Expertise in Medicines, Ministry of Health of the Russian Federation

Email: MoiseevSV@expmed.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies